MODERNA, INC.

MRNA
Real-time Estimate Cboe BZX - 11:14 2022-12-07 am EST
179.74 USD +3.57%

Turn to zoom
Prev.173.54000000
Open172.31000000
High180.23000000
Low171.85000000
Volume1 065 349
Latest news
22h ago
23h ago
23h ago
1d ago
Chart MODERNA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance185194254
Spread/Res.-3,3%-7,6%-29%
Spread/Supp.9,9%53%52%
Support163117118
Financials
Sales 2022 19 089 M - -
Net income 2022 8 897 M - -
Net cash 2022 12 022 M - -
P/E ratio 2022 8,05x
Yield 2022 -
Capitalization 66 671 M 66 671 M -
EV / Sales 2022 2,86x
EV / Sales 2023 6,03x
Nbr of Employees 2 700
Free-Float 90,3%
Company
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
-...
Sector :
Other Biotechnology & Medical Research
Calendar :
2023-02-23 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 173,54 $
Average target price 211,25 $
Spread / Average Target 21,7%